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ABSTRACT
Objective: The aim of this study was to optimize and validate a plasma clopidogrel analysis method using liquid chromatography tandem-mass 
spectrometry.
Methods: Plasma samples were analyzed using a BEH C18 column (1.7 μm; 100 mm×2.1 mm), the mobile phase was 0.1% formic acid in acetonitrile 
(30:70, v/v). The flow rate was 0.2 mL/min, with a column temperature set to 35°C, an injection volume of 5 μL, an analysis time of 4 min, and 
irbesartan as the internal standard. Aliquots were obtained by liquid-liquid extraction using ammonium acetate and diethyl ether. The stability and 
peak area ratio of the respective plasma area responses were evaluated using ANOVA.
Results: No significant differences (p>0.05) were observed between anticoagulants regarding analyte stability. However, the peak area ratio 
showed significant differences (p<0.05) between the anticoagulants. The accuracy and precision of the analysis with citrate, heparin, and 
ethylenediaminetetraacetic acid (EDTA) plasma met the quality requirements, and a linear calibration curve was created with concentrations ranging 
from 0.02 to 5.0 ng/mL.
Conclusion: The results showed that improved analysis of clopidogrel was achieved using citrate or heparin plasma compared with EDTA plasma.
Keywords: Citrate, Clopidogrel, Ethylenediaminetetraacetic acid, Heparin, Liquid chromatography tandem-mass spectrometry.
INTRODUCTION
Clopidogrel is one of the slowest-onset action prodrugs (Brunton, 
Lazo, and Parker, 2006) and is the drug of choice for antiplatelet 
agents [1]. Clopidogrel is also used as secondary prevention of 
cerebral and cerebrovascular infarction in patients who do not tolerate 
acetylsalicylic acid or experience new attacks while using acetylsalicylic 
acid [2]. Clopidogrel is adenosine diphosphate receptor antagonist and 
irreversibly inhibits platelet function [3].
The maximum concentration of clopidogrel in plasma is reportedly very 
low, that is, 7921.49±3921.39 pg/mL [4]. Thus, developing accurate 
analytical methods for clopidogrel are important, particularly for the 
examination and monitoring of clopidogrel levels in plasma, which is 
the most common biological matrix for the analysis of drugs in the body. 
Plasma is obtained from blood samples with the use of anticoagulants. 
Thus, an important factor when obtaining plasma is the type of 
anticoagulant used and studies often use different anticoagulants, 
making comparisons between analytical methods difficult [5,6]. The 
ethylenediaminetetraacetic acid (EDTA), heparin, and citrate are 
anticoagulants often used in drug [5].
The anticoagulants themselves are generally present in the blood 
collection tube at a concentration sufficient to inhibit blood clotting, as 
the use of excess concentrations may lead to undesirable effects during 
bioanalysis [7]. However, the use of anticoagulants can lead to errors 
during the analysis of certain drugs [8]. Thus, selecting the appropriate 
anticoagulant during drug analysis serves to provide many benefits, 
including minimizing interferences and improving the stability of 
the drug and/or its metabolites [7]. Indeed, differences between 
anticoagulants have been known to affect the measurement of small 
molecules [9], metabolic profiles [6,10], and clinical parameters of 
the drug being analyzed [11-13]. In addition, some of the ions (e.g., Na 
+ or K +) present in the plasma anticoagulant such as Na-citrate and 
K-EDTA may cause ion suppression or ion enhancement of the drug 
and its metabolites, which may affect analysis [6]. Moreover, for plasma 
drug analysis, a selective and sensitive bioanalysis method is required 
because the plasma level of clopidogrel is very low [14]. Ultra-high-
performance liquid chromatography tandem-mass spectrometry 
(UHPLC-MS/MS) with electrospray ionization (ESI) is a specific and 
sensitive method of analysis that has become the standard for the 
measurement of drugs, metabolites and endogenous compounds in 
biological matrices [15].
This study was conducted to evaluate the commonly used anticoagulant 
types, namely, citrate, heparin, and EDTA, on parameters such as 
stability, recovery, matrix effect, and area response of the analyte.
MATERIALS AND METHODS
Materials
Standard clopidogrel (MSN Laboratories, India) and standard irbesartan 
(Zhejiang Huahai Pharmaceutical, China) were purchased. Blood was 
taken directly from healthy subjects, and plasma was obtained using 
the citrate anticoagulant citrate phosphate dextrose adenine (CPD-A) 
(Indonesian Red Cross). Reagents were high PLC (HPLC)-grade and 
included acetonitrile, formic acid, diethyl ether, and ammonium acetate 
were purchased from Merck.
Tools
A ultra PLC-MS/MS (UPLC-MS/MS) system (Waters Xevo TQD Triple 
Quadrupole) consisting of a quaternary solvent manager (Acquity UPLC 
H-Class), Sample ManagerFTN (Acquity UPLC), a nitrogen generator 
compressor (PEAK Scientific), a BEH C18 column (Waters Acquity™ 
UPLC 100.0 mm×2.1 mm, 1.7 μm), a triple quadrupole (Xevo TQD) mass 
analyzer with an ionization source (Zspray™), data processing software 
(MassLynx Software), and a computer was used. Other equipment used 
included vacuum tubes or Vacutainers with K3EDTA anticoagulant 
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(Vacuette®), vacuum tubes with the anticoagulant Li-Heparin 
(Vacuette®), blood collection tubes (BD Vacutainer® Beckton, Dickson 
and Company), analytical scales (Acculab), degasser (Elmasonic S40H), 
evaporator (Turbovap), centrifuge (Digital Lab Centrifuge), vortex 
(Maxi Mix II), pH meter (pH Eutech 510), refrigerator (4–8°C), freezers 
(−20°C and −80°C) (Biomedical Labtech DeepFreeze), Eppendorf tubes 
(Soccorex), centrifugation tubes, blue tips, yellow tips, and various 
glassware.
Sample preparation
The quantitative determination of an analyte and its metabolites in a 
biological matrix takes place in several stages, including sample storage, 
sample preparation, separation, identification, and analyte quantification. 
Sample preparation has three principles: Dissolution of the analyte in a 
suitable solvent, the removal of any interfering compounds, and the pre-
concentration of the analyte. Some of the techniques employed include 
protein precipitation, liquid-liquid extraction, solid phase extraction, and 
ultrafiltration. In this research, the sample preparation used liquid-liquid 
extraction using ammonium acetate and diethyl ether.
Chromatography condition
Chromatographic separation is based on the transfer of a liquid (mobile 
phase) carrying the analytical mixture through a stationary medium. 
The interaction difference of the analyte with the surface of the medium 
results in a difference in retention time between the components of the 
mixture [16-20]. UPLC differs from other chromatographic methods in 
the size of the column particles is substantially smaller. With UPLC, the 
speed of analysis and peak capacity is maximized. In addition, solvents 
are used less due to the high analysis speeds; thus, UPLC improves 
efficiency and resolution [21]. Small diameter UPLC diameter particles 
(<2.0 μm) can improve efficacy (Waters, 2016). The instrumentation 
of a UPLC system is almost the same as LC and generally consists 
of a solvent reservoir, pump, injector, column, detector, and a data 
processing system. The bridged ethylene hybrid column (BEH) has the 
advantage of high retentivity for basic compounds, good peak shape at 
high pH, universal columns for various compounds, stability at various 
pHs and can be used for separation at high temperatures (80 °C) [17].
Analysis conditions
The analytical method used in this study was UPLC. For analysis, was 
used C18 columns (100 mm×2.1 mm, 1.7 μm), a 0.1% formic acid 
filtration phase in 0.1% formic acid solution in acetonitrile (30:70, v/v), 
as mobile phase isocratic elution at 0.2 mL/min flow rate, and a 35°C 
column temperature. MS detection using the ESI positive ionization 
method and MRM was performed with capillary tubing of 3.5 kV, a 
desecration gas temperature of 400°C, a dissolved gas flow rate of 
800 L/h. The obtained m/z values were the molecular weight of the 
parent ion and the molecular weight of the productions. The molecular 
weight value of clopidogrel was 321.8 g/mol, while that of irbesartan 
was 428.5 g/mol, with clopidogrel at m/z 322.086>212.097 and 
irbesartan at m/z 429.233>207.131.
System suitability test
Clopidogrel and irbesartan standards were carefully weighed and 
placed into a measuring flask and dissolved with acetonitrile to the 
measurement limit to obtain a solution of 1 mg/mL (1000 μg/mL). 
The two dilutes were diluted again to the concentration of the system 
suitability test solution and the concentration solution of the calibration 
curve. A 100 ng/mL clopidogrel mixture solution was injected (as much 
as 10.0 μL) into the chromatography system. Injection results were 
recorded and counted for the return value (%KV) over five different 
injections. The calculated parameters were the areas and times of peak 
analytical and internal retention peaks.
Blood sampling and plasma preparation
Plasma with the citrate anticoagulant CPD-A was obtained from the 
Indonesian Red Cross (Palang Merah Indonesia), while blood plasma 
with the anticoagulants heparin and EDTA was obtained from the 
separation of blood samples taken from six healthy subjects that gave 
informed consent. Blood samples were divided into two vacuum tubes, 
each containing anticoagulants in the form of Li-Heparin and K3EDTA. 
Blood in each vacuum tube was inverted 10 times to mix the blood 
with the anticoagulant in the tube. The vacuum tube was centrifuged 
at 3000 rpm for 10 min at room temperature. The plasma was then 
transferred to another clean tube. Plasma was stored in a freezer at 
−80°C until analysis.
Sample preparation
A total of 250 μL plasma containing clopidogrel of a certain 
concentration plus 20 μL irbesartan (100 ng/mL) was vortexed for 
10 s. Plasma with ammonium acetate (0.05 M; pH 6.8) was vortexed for 
10 s. The extraction was performed with the addition of diethyl ether, 
vortexed, and centrifuged at 13,000 rpm for 10 min. A total of 750 μL of 
the organic phase was separated into clean tubes to evaporate and dry 
at 60°C for 10 min. The obtained residue was reconstituted in 150 μL 
acetonitrile, vortexed for 10 s, sonicated for 10 s, and vortexed again for 
10 s. The final solution was transferred to a vial insert and centrifuged 
at 3000 rpm for 5 min. A total of 5.0 μL of the final solution was injected 
into the chromatographic system.
RESULTS AND DISCUSSION
The internal standard used irbesartan because it has similar 
physicochemical properties to clopidogrel, particularly its acidity and 
solubility; thus, it can be detected and eluted using the same analytical 
method. The analytical conditions resulted in a good separation 
between the analyte and the standard with clopidogrel retention of 
2.68 min and an irbesartan retention of 1.16 min. A relatively short run 
time of 4 min was also considered a good achievement of this method.
Liquid-liquid extraction methods can produce larger analytical 
areas [12]. In this study, the liquid-liquid extraction method was 
optimized. Liquid-liquid extraction is best used for analysis using 
HPLC-MS/MS because it does not damage the column when compared 
with the protein precipitation method. In addition, the resulting area 
response is greater due to the drying process, and fewer additional 
solvents (concentration process) are used. The optimization of the 
liquid-liquid extraction process conducted in this study was aimed 
to obtain an efficient and rapid extraction step so as to minimize 
contamination. However, during liquid-liquid extraction, an emulsion 
can sometimes form during processing, so the process needs to be 
repeated. Thus, a full validation was performed on plasma citrate [22].
Comparison of clopidogrel analysis in three types of anticoagulants
The different characteristics of each anticoagulant, including their 
different physicochemistry, plasma pH, and ion type differences, it was 
necessary to analyze three types of anticoagulants by observing the 
chromatograms and parameters produced by each plasma, including 
the recovery value, peak area ratio, the stability of the analytes, and 
matrix effects.
Comparison of the chromatograms and spectrums for all three 
plasmas
Observations were made by comparing the plasma chromatograms, 
which showed no significant differences. Other observations were 
made by comparing the spectrum of the blanks for each plasma. The 
matrix effect of the three plasmas showed no significant differences.
Comparison of clopidogrel area responses in all three plasmas
Based on the data analysis on Peak Area Ratio (PAR), the obtained 
p<0.05 (Kruskal–Willis) for all concentrations. This showed that there 
was a significant difference between the PAR values generated from the 
three types of plasma. Furthermore, further statistical analysis using 
the Mann–Whitney method for two types of plasma indicated that the 
ratio of the citrate-heparin plasma at all concentrations has a p>0.05, 
indicating no significant difference. In contrast, plasma citrate-EDTA 
and heparin-EDTA analysis had a value of p<0.05, meaning that there 
was a significant difference.
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Comparison of the recovery values of all three plasmas
Observations were made statistically on the concentrations of quality 
control low (QCL) and Quality control high (QCH). At the concentration 
of QCL and QCH for the recovery for the three types of plasma, obtained 
a p<0.05, indicating a significant difference. In the comparative analysis 
of the recovery values obtained statistically for the concentration of 
QCL and QCH, p<0.05 also indicated significant differences. This may 
be due to the very small concentrations of the analysis, which were 
in the picogram per milliliter range, thus the recovery of each plasma 
varied.
Comparison of clopidogrel stability for all three plasma samples
Based on the results of the study (Table 1), clopidogrel was stable in 
plasma citrate, plasma heparin, and plasma EDTA for short-term storage 
and autosampler. For long-term stability stored at −20°C, clopidogrel 
was stable for at least 21 days in all three types of plasma. Based on the 
stability data, there were no significant differences in the stability of 
clopidogrel in plasma citrate, heparin, and EDTA.
CONCLUSION
The analytical method met the requirements based on EMEA guidelines 
from 2011 for all three types of plasma (citrate, heparin, and EDTA). 
In addition, clopidogrel analysis in plasma citrate or heparin provides 
better results than in plasma EDTA.
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